CANDICE BOLANDER: Open Payments
NPI 1902686124 · HARVEY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 48 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $448 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $216 |
| AstraZeneca Pharmaceuticals LP | 8 | $174 |
| Lilly USA, LLC | 11 | $143 |
| COLOPLAST CORP | 1 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $86 |
| Alkermes, Inc. | 1 | $66 |
| PFIZER INC. | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
Products named: MOUNJARO, Altis, AIRSUPRA, UBRELVY, CREON, JARDIANCE, VIVITROL, BREZTRI.
Industry payments across LA — which companies pay providers there.
